Upcoming Events

RAPS Convergence 2024

September 17, 2024 — September 19, 2024
Long Beach, CA
Long Beach Convention & Entertainment Center

RAPS Convergence 2024 Focus: Human in the Lead.

As if keeping track of the changing regulatory environment wasn’t enough! The past few years have presented new challenges like the rise of AI and at a time when regulatory professionals collaborate in person less often than before. At RAPS Convergence 2024, we’ll gather to share knowledge and collaborate on solutions using the best resources we have — each other. This conference is where we can cut through the noise and confusion and learn face-to-face with experts and peers.

Schedule A Meeting Now

Please share your details to schedule a meeting with MMS representatives at this event, and let’s explore a future where accuracy, innovation, and unparalleled expertise drive your success.

Suggested For You

perspectives

July 1st, 2025

Why Real-Time Data Access Matters (and How to Make the Most of It)

webinar

July 31st, 2025

Design, Data, and Decisions in Oncology Trials

perspectives

June 24th, 2025

Why Now Is the Time for Specialized, Data-Focused CRO Partners

news

June 19th, 2025

MMS Wins in the 2025 Fierce CRO Awards for Excellence in Client Service and Partnership and Dr. Uma Sharma Named CRO Champion 

perspectives

June 17th, 2025

Solving Data Complexity with Real-Time Insights, Predictive AI, and Smarter Decision-Making with Datacise

regulatory intelligence

June 16th, 2025

Key MedDRA Coding Gaps Highlighted at the ISCTM 2025 Scientific Meeting

perspectives

June 10th, 2025

Applying Artificial Intelligence (AI) and Real-World Evidence to Boost Efficiency in Patient Safety Narratives 

perspectives

June 3rd, 2025

Choosing the Right Strategy: Parallel, Sequential, and Staggered Regulatory Submissions 

news

May 28th, 2025

MMS Named Finalist for Fierce CRO Award in Excellence in Client Service and Partnership, CEO shortlisted for the CRO Champion Award 

perspectives

May 28th, 2025

A Season of Change: Why the REMS Industry Consortium Matters More Than Ever

perspectives

May 20th, 2025

Navigating FDA OMOR Meetings: A Comprehensive Guide to Type X, Y, and Z Meetings for OTC Drug Sponsors

perspectives

May 6th, 2025

Why Clinical Trial Simulation Is Reshaping Drug Development: A Q&A with Dr. Aiden Flynn